Related Experiment Video

Updated: Oct 27, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.5K

Precision oncology: a clinical and patient perspective

Ulrik N Lassen1, Lydia E Makaroff2,3, Albrecht Stenzinger4

  • 1Rigshospitalet, Copenhagen, 2100, Denmark.

Future Oncology (London, England)
|July 19, 2021
PubMed

Insights

Precision oncology targets specific mutations for better cancer treatment, moving beyond traditional therapies. Understanding patient perspectives is key to advancing personalized cancer care and overcoming treatment challenges.

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Cancer treatment is shifting from histology-specific cytotoxic therapies to targeting actionable mutations across tumor types.
  • High-throughput technologies like next-generation sequencing are crucial tools for optimizing cancer management.
  • Precision oncology has demonstrated success in improving patient outcomes and quality of life.

Purpose of the Study:

  • To review the current status of precision oncology medicine.
  • To emphasize the impact of precision oncology on patients.
  • To explore patient understanding and future hopes for precision oncology.

Main Methods:

  • Review of current literature and clinical applications of precision oncology.
  • Analysis of patient perspectives and experiences with precision oncology.
  • Discussion of challenges and future directions in precision oncology.

Main Results:

  • Precision oncology enables targeted therapies based on molecular tumor characteristics.
  • Advanced technologies and databases support personalized treatment strategies.
  • Precision oncology improves outcomes, quality of life, and drug resistance management.

Conclusions:

  • Precision oncology represents a paradigm shift in cancer care, offering targeted treatment strategies.
  • Continued research and addressing implementation challenges are vital for maximizing its benefits.
  • Understanding patient perspectives is essential for the future development and adoption of precision oncology.
Keywords:
outcomesprecision oncologyquality of lifetumor-agnostic therapy

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.3K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.0K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
482
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K